U.S. philanthropist and entrepreneur Bill Gates has opened up about the search for a lifetime HIV vaccine, rather than one ...

Research shows many transgender women in the U.S. express interest in long-acting injectable PrEP but face barriers to ...

Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations ...

The following is a summary of “Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies,” ...

The number of new HIV infections and deaths is falling worldwide, marking significant progress in the fight against the ...

While Gilead has yet to bring a vaccine to market, that could be about to change after a phase 3 trial this year showed that ...

Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...

Many family physicians may be unaware of doxy PEP as a means of avoiding STIs. “Doxy PEP is an incredible tool that can be ...

The US Agency for International Development (USAID) teamed up with Ayala Healthcare Holdings Inc. (AC Health) to strengthen ...